CARA THERAPEUTICS INC (CARA)
US1407551092 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 23M -82.98% | 41.9M 82.17% | 20.968M -49.96% | 6.757M -67.77% | 6.554M -3.00% | 7.416M 13.15% | 19.327M 160.61% | 51.768M 167.85% | 65.919M 27.34% | 39.101M -40.68% | 334.14M 754.56% | |
| EBITDA YoY % growth | -88.85M -1,683.78% | -87.25M 1.80% | -121.236M -38.95% | -69.888M 42.35% | -66.289M 5.15% | -64.714M 2.38% | -57.964M 10.43% | -56.107M 3.20% | -61.364M -9.37% | -53.786M 12.35% | 183.91M 441.93% | |
| EBIT YoY % growth | -89.1M -1,750.00% | -87.5M 1.80% | -121.495M -38.85% | -73.57M 39.45% | -53.062M 27.88% | -46.776M 11.85% | -50.912M -8.84% | -32.287M 36.58% | -26.092M 19.19% | -53.786M -106.14% | 164.75M 406.31% | |
| Operating Margin | -387.39% | -208.83% | -579.43% | -1,088.80% | -809.61% | -630.75% | -263.42% | -62.37% | -39.58% | -137.56% | 49.31% | |
| EPS YoY % growth | -1.73 -2,262.50% | -1.59 8.09% | -2.18 -37.11% | -1.31 39.95% | -0.79 40.00% | -0.65 17.75% | -0.73 -12.90% | -0.61 16.78% | -0.37 39.50% | -0.73 -100.00% | 1.80 344.44% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 67.15% | -0.20 63.57% | -0.21 42.11% | -0.23 -2.00% | -0.20 -5.26% |
| Revenue Q2Q % growth | 1.628M -45.81% | 1.224M -42.67% | 1.02M 2.93% | 816K -68.08% | 612K -62.41% |
| EBITDA Q2Q % growth | -12.577M 61.12% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -12.244M 62.45% | -16.83M 38.27% | -17.952M -21.92% | -19.482M -268.91% | -21.42M -74.94% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.23 55.77% | -0.25 | 0.02 | 8.59% |
| Q2 2024 Q2Q % growth | -0.37 36.21% | -0.28 | -0.09 | -32.39% |
| Q1 2024 Q2Q % growth | -0.56 -14.29% | -0.41 | -0.15 | -37.94% |
| Q4 2023 Q2Q % growth | -0.59 -5.36% | -0.42 | -0.17 | -40.40% |
| Q3 2023 Q2Q % growth | -0.52 -20.93% | -0.53 | 0.01 | 1.96% |
| Q2 2023 Q2Q % growth | -0.58 -625.00% | -0.55 | -0.03 | -5.63% |
| Q1 2023 Q2Q % growth | -0.49 5.77% | -0.53 | 0.04 | 7.87% |
| Q4 2022 Q2Q % growth | -0.56 11.11% | -0.33 | -0.23 | -71.57% |
| Q3 2022 Q2Q % growth | -0.43 -2,050.00% | -0.43 | 0.00 | -0.72% |
| Q2 2022 Q2Q % growth | -0.08 86.89% | -0.26 | 0.18 | 69.04% |
| Q1 2022 Q2Q % growth | -0.52 -10.64% | -0.55 | 0.03 | 5.01% |
| Q4 2021 Q2Q % growth | -0.63 -139.62% | -0.53 | -0.10 | -19.77% |
| Q3 2021 Q2Q % growth | -0.02 94.29% | -0.40 | 0.38 | 95.04% |
| Q2 2021 Q2Q % growth | -0.61 -12.96% | -0.54 | -0.07 | -12.23% |
| Q1 2021 Q2Q % growth | -0.47 24.19% | -0.60 | 0.13 | 21.90% |
| Q4 2020 Q2Q % growth | 1.59 360.66% | 0.37 | 1.22 | 327.91% |
| Q3 2020 Q2Q % growth | -0.35 52.70% | -0.61 | 0.26 | 42.54% |
| Q2 2020 Q2Q % growth | -0.54 6.90% | -0.68 | 0.14 | 20.47% |
| Q1 2020 Q2Q % growth | -0.62 -10.71% | -0.63 | 0.01 | 1.76% |
| Q4 2019 Q2Q % growth | -0.61 -17.31% | -0.67 | 0.06 | 9.24% |
| Q3 2019 Q2Q % growth | -0.74 -45.10% | -0.59 | -0.15 | -25.32% |
| Q2 2019 Q2Q % growth | -0.58 -11.54% | -0.63 | 0.05 | 7.39% |
| Q1 2019 Q2Q % growth | -0.56 -9.80% | -0.59 | 0.03 | 4.61% |
| Q4 2018 Q2Q % growth | -0.52 | -0.59 | 0.07 | 12.40% |
| Q3 2018 Q2Q % growth | -0.51 | -0.51 | 0.00 | 0.88% |
| Q2 2018 Q2Q % growth | -0.52 | -0.32 | -0.20 | -60.57% |
| Q1 2018 Q2Q % growth | -0.51 | -0.48 | -0.03 | -5.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.556M -47.47% | 1.649M | 907K | 55.00% |
| Q2 2024 Q2Q % growth | 991K -85.71% | 1.197M | -206K | -17.21% |
| Q1 2024 Q2Q % growth | 2.135M -65.37% | 1.724M | 411K | 23.84% |
| Q4 2023 Q2Q % growth | 3.004M -8.97% | 9.61M | -6.606M | -68.74% |
| Q3 2023 Q2Q % growth | 4.866M -54.94% | 10.15M | -5.284M | -52.06% |
| Q2 2023 Q2Q % growth | 6.933M -69.86% | 6.693M | 240K | 3.59% |
| Q1 2023 Q2Q % growth | 6.165M 28.44% | 5.082M | 1.083M | 21.31% |
| Q4 2022 Q2Q % growth | 3.3M 312.50% | 16.576M | -13.276M | -80.09% |
| Q3 2022 Q2Q % growth | 10.8M -46.80% | 10.027M | 773K | 7.71% |
| Q2 2022 Q2Q % growth | 23M | 21.121M | 1.879M | 8.90% |
| Q1 2022 Q2Q % growth | 4.8M 152.63% | 3.227M | 1.573M | 48.74% |
| Q4 2021 Q2Q % growth | 800K -99.29% | 1.487M | -687K | -46.20% |
| Q3 2021 Q2Q % growth | 20.3M 118.28% | 11.431M | 8.869M | 77.59% |
| Q2 2021 Q2Q % growth | -100.00% | 2.645M | -2.645M | -100.00% |
| Q1 2021 Q2Q % growth | 1.9M -76.54% | 2.405M | -505K | -21.00% |
| Q4 2020 Q2Q % growth | 112.1M 2,391.11% | 49.601M | 62.499M | 126.00% |
| Q3 2020 Q2Q % growth | 9.3M 60.34% | 4.867M | 4.433M | 91.08% |
| Q2 2020 Q2Q % growth | 5.6M 7.69% | 5.158M | 442K | 8.57% |
| Q1 2020 Q2Q % growth | 8.1M 84.09% | 4.856M | 3.244M | 66.80% |
| Q4 2019 Q2Q % growth | 4.5M -18.18% | 4.884M | -384K | -7.86% |
| Q3 2019 Q2Q % growth | 5.8M 13.73% | 4.426M | 1.374M | 31.04% |
| Q2 2019 Q2Q % growth | 5.2M 79.31% | 3.116M | 2.084M | 66.88% |
| Q1 2019 Q2Q % growth | 4.4M | 3.02M | 1.38M | 45.70% |
| Q4 2018 Q2Q % growth | 5.5M | 2.727M | 2.773M | 101.69% |
| Q3 2018 Q2Q % growth | 5.1M | 3.465M | 1.635M | 47.19% |
| Q2 2018 Q2Q % growth | 2.9M | 6.598M | -3.698M | -56.05% |
| Q1 2018 Q2Q % growth | 31.957K | -31.957K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 25.49% | 0% | 0.32% |
| Revenue | 0% | 22.13% | 0% | 0.85% |